Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
25000 participants
OBSERVATIONAL
2007-05-31
2027-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Genetic and Biochemical Markers of Interferon-Induced Depression.
NCT00252538
Gut Microbiome and Depression
NCT05808101
Integrating Pharmacogenomic Testing Into a Child Psychiatry Clinic
NCT02855580
Feasibility of Resistance Exercise to Treat Major Depression Via Cerebrovascular Mechanisms
NCT05695365
Study of Genes in Relation to Seasonal Affective Disorder and Major Depressive Disorder
NCT01292889
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Goal 1) Assess the prevalence and development of depression among medical interns
Although small studies have assessed the point prevalence of depression among medical residents, no study has prospectively followed the development of depressive symptoms through residency. We will collect baseline psychological profiles of incoming interns prior to the commencement of residency duties and subsequently assess for depressive symptoms at 3-month intervals throughout internship. This data will allow us to:
1. Assess the point prevalence of depression among interns in a large sample.
2. Determine the change in depressive symptoms through the course of the intern year
3. Evaluate stable psychological factors that associate with the development of depression in the face of life stress.
Goal 2) Evaluate the presence of genotype x stress interaction among this sample
1. There is conflicting evidence concerning the presence of an interaction between the serotonin transporter promoter polymorphism (5-HTTLPR) and life stress in the development of depression. We will assess the presence and strength of this interaction in the sample of medical interns using a study design that avoids many of the pitfalls affecting previous studies.
2. We will explore novel putative interactions between stress and genetic variants in additional genes including BDNF, CRH, COMT, serotonin 1A and serotonin 2A receptor variants in the development of depression.
Goal 3) Evaluate the relationship between serum endothelial and immune factors and the development of depressive symptoms under stress.
The identification biomarkers that predict the onset of depression can facilitate more timely and accurate identification of individuals at high risk for the disorder. Unfortunately appropriate studies are lacking, largely because it is difficult to know exactly when a depressive episode will occur. Medical internship represents a rare situation where we can prospectively predict when a cohort of individuals shift will shift from a low stress environment to a high stress environment and thus predict when this cohort will experience a dramatic increase in depressive symptoms.
Goal 4) Examine the temporal relationship between hair cortisol levels, stress exposure and development of depressive symptoms.A novel technique allows us to assess chronic HPA axis activity by measuring cortisol in the growing hair, providing an integrated measure of total cortisol secretion over extended periods of time (1-3 months).
By incorporating this novel method into an established longitudinal study of a chronic stressor that dramatically increases rates of depression, we have a unique opportunity to determine a) whether cortisol levels prior to stress exposure predict risk of depression in response to the stressor (b) whether cortisol rise in response to stress exposure precedes and perhaps contributes to development of depressive symptoms or whether cortisol elevations in depression develop after symptom onset and perhaps reflect a consequence of depression.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
2020
No interventions assigned to this group
2019
No interventions assigned to this group
2018
No interventions assigned to this group
2017
No interventions assigned to this group
2016
No interventions assigned to this group
2015
No interventions assigned to this group
2014
No interventions assigned to this group
2013
No interventions assigned to this group
2012
No interventions assigned to this group
2011
No interventions assigned to this group
2010
No interventions assigned to this group
2009
No interventions assigned to this group
2008
No interventions assigned to this group
2007
No interventions assigned to this group
2021
No interventions assigned to this group
2022
No interventions assigned to this group
2023
No interventions assigned to this group
2024
No interventions assigned to this group
2025
No interventions assigned to this group
2026
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Michigan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Srijan Sen
Assistant Professor of Psychiatry, Medicial School
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Srijan Sen, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Michigan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Michigan Medical School
Ann Arbor, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Karg K, Sen S. Gene x environment interaction models in psychiatric genetics. Curr Top Behav Neurosci. 2012;12:441-62. doi: 10.1007/7854_2011_184.
Guille C, Sen S. Prescription drug use and self-prescription among training physicians. Arch Intern Med. 2012 Feb 27;172(4):371-2. doi: 10.1001/archinternmed.2011.791. No abstract available.
Guille C, Speller H, Laff R, Epperson CN, Sen S. Utilization and barriers to mental health services among depressed medical interns: a prospective multisite study. J Grad Med Educ. 2010 Jun;2(2):210-4. doi: 10.4300/JGME-D-09-00086.1.
Sen S, Kranzler HR, Krystal JH, Speller H, Chan G, Gelernter J, Guille C. A prospective cohort study investigating factors associated with depression during medical internship. Arch Gen Psychiatry. 2010 Jun;67(6):557-65. doi: 10.1001/archgenpsychiatry.2010.41. Epub 2010 Apr 5.
Karg K, Burmeister M, Shedden K, Sen S. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch Gen Psychiatry. 2011 May;68(5):444-54. doi: 10.1001/archgenpsychiatry.2010.189. Epub 2011 Jan 3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MH-095109
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.